Trial Profile
11C-erlotinib brain uptake in Diffuse Intrinsic Pontine Glioma imaged by PET
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 23 Feb 2023
Price :
$35
*
At a glance
- Drugs Erlotinib (Primary)
- Indications Diffuse intrinsic pontine glioma; Glioma
- Focus Diagnostic use
- Acronyms 11C-Erlotinib in DIP
- 23 Feb 2023 Status changed from recruiting to discontinued.
- 19 May 2018 Status changed to recruiting.
- 08 May 2018 New trial record